Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Katsuyuki Kiura

ILD During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Phase II Trial of Gefitinib in Combination With Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer With Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001

Journal of Thoracic Oncology

English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Journal of Thoracic Oncology

English

Aberrant DNA Methylation Profile in Pleural Fluid for Differential Diagnosis of Malignant Pleural Mesothelioma

English

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

English

Requirement for Neuropeptide Y in the Development of Type-2 Responses and Allergen-Induced Airway Hyperresponsiveness and Inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

English

A Retinoid X Receptor Partial Agonist Attenuates Pulmonary Emphysema and Airway Inflammation

English

MET or NRAS Amplification Is an Acquired Resistance Mechanism to the Third-Generation EGFR Inhibitor Naquotinib

Scientific Reports

Multidisciplinary

2018

English

Everolimus Prolonged Survival in Transgenic Mice With EGFR-driven Lung Tumors

Experimental Cell Research

Cell Biology

2014

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Katsuyuki Kiura

ILD During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer

Phase II Trial of Gefitinib in Combination With Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer With Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

Aberrant DNA Methylation Profile in Pleural Fluid for Differential Diagnosis of Malignant Pleural Mesothelioma

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

Requirement for Neuropeptide Y in the Development of Type-2 Responses and Allergen-Induced Airway Hyperresponsiveness and Inflammation

A Retinoid X Receptor Partial Agonist Attenuates Pulmonary Emphysema and Airway Inflammation

MET or NRAS Amplification Is an Acquired Resistance Mechanism to the Third-Generation EGFR Inhibitor Naquotinib

Everolimus Prolonged Survival in Transgenic Mice With EGFR-driven Lung Tumors